NewAge, Inc. (Nasdaq: NBEV), the Colorado-based
direct-to-consumer (D2C) organic and healthy products company,
today announced record financial results for the second quarter of
2021 with a net revenue of $124 million, net income of $17.4
million, adjusted EBITDA1 of $1.7 million, and basic earnings per
share of $0.11.
For the three months ending June 30, 2021, net
revenue was $124 million, an increase of $61 million or 98%. Gross
profit for the quarter was $84 million, an increase of $46 million
or 120%, resulting in a gross margin of 67.6%, compared to a 60.8%
in the prior-year period, an increase of 6.8 percentage points. Net
income was $17.4 million, an increase of $26.9 million compared ot
a net loss of ($9.6) million in the prior-year period. Adjusted
EBITDA was $1.7 million, an increase of $7.2 million compared to a
loss of ($5.5) million in the prior-year period. Basic earnings per
share was a positive $0.11, an increase of $0.21 compared to a loss
of ($0.10) in the prior-year period.
Brent Willis, Chief Executive Officer of NewAge,
commented, “The second quarter saw accelerated top and bottom-line
results and continued income statement improvement. In the quarter,
we completed the Aliven acquisition, had a very successful annual
meeting, further integrated ARIIX capturing additional cost and
revenue synergies, and continued expansion of our social selling
initiatives worldwide. We strengthened our team and positioned
NewAge for even further transformative performance as our strategy
unfolds.”
“This is our third consecutive quarter of
positive adjusted EBITDA,” commented Kevin Manion, NewAge’s new
Chief Financial Officer. “Financially, our focus is on developing,
utilizing and driving consistent company-wide metrics to improve
EBITDA margins through operational improvements and reducing
SG&A costs, specifically from consolidating the recent
acquisitions. With these activities, we are confident in continued
growth throughout 2021 and thereafter. I see NewAge as extremely
well positioned to deliver superior organic growth and
transformative, accretive external growth. I have spent most of my
career in the consumer goods industry and see the NewAge Social
Selling Network and our D2C route-to-market as the new winning
industry model that will deliver outsized returns for
shareholders.”
Second Quarter 2021 Financial
Results
Net revenue was $124 million for the three
months ending June 30, 2021, versus $63 million for the second
quarter of the prior year, an increase of 98%. The growth in net
revenue was driven by the acquisitions of ARIIX and
Aliven. Leading the growth on a proforma basis was the
combined European business that increased 24% and the United States
business that increased 15%. These were offset by China, Japan and
the impact of COVID-19 in a number of markets around the world.
Gross margin for the second quarter of 2021 was
$84 million or 67.6% of net revenue compared with $38 million or
60.8% of net revenue for the prior-year period, a 120% increase of
$46 million and an increase of 6.8 gross margin percentage points.
The gross margin percentage increase was driven by higher net
revenue from the Direct/Social Selling Division and the disposition
of the retail brands’ business completed in September
2020.
Net operating loss was ($9.6) million for the
second quarter of 2021 compared to a loss of ($8.8) million for the
prior-year period. Net income was $17.4 million, correlating
to a positive basic EPS of $0.11 per share, an increase of 21 cents
from the prior-year period. Adjusted EBITDA was $1.7 million,
compared with ($5.5) million for the prior-year period, an
improvement of $7.2 million.
The company ended the quarter with a strong
balance sheet, with cash and cash equivalents of $92 million and
debt of $31.5 million, exclusive of operating lease liabilities.
Subsequent to the quarter-end, $9.7 million of debt was
forgiven.
“Our second-quarter results demonstrated
commendable progress converging our companies and capturing both
revenue and cost synergies. Carrying this momentum forward, we
expect continued strong results from operations throughout the year
as we build out additional platforms and programs for our global
sales force. We believe we are stronger and better positioned than
we have ever been, with differentiated health and wellness brands
and an on-trend D2C business system, with an expanding e-commerce
Subscriber base and an increasing and strengthening team of
exclusive Brand Partner influencers,” concluded Mr. Willis.
Conference Call
The company will host a live conference call and
webcast today at 5:00 p.m. Eastern Time. Conference call details
are provided below. Interested investors can dial into the
conference call to hear the details of management's updates and
participate in a question and answer session.
Date: Monday, August 9,
2021Time: 5:00 p.m. ETToll-free
dial-in number: 1-855-327-6838International
dial-in number: 1-604-235-2082Conference
ID: 10016023
The conference call will also be broadcast live
and available for replay here and via the Investors section of
the company’s website at newage.com. The webcast replay will be
available for approximately 45 days following the call.
Please dial into the conference call 15 minutes
prior to the start time due to increased demand for conference
calls. You will be asked to register your name and
organization.
A replay of the conference call will be
available after 8:00 p.m. Eastern Time on the same day through
Monday, August 16, 2021, 11:59 p.m.
Toll-free replay
number: 1-844-512-2921International replay
number: 1-412-317-6671Replay
ID: 10016023
About NewAge, Inc.NewAge is a
purpose-driven firm dedicated to inspiring the planet to Live
Healthy™. Colorado-based NewAge commercializes a portfolio of
organic and healthy products worldwide through primarily a
direct-to-consumer (D2C) route to market distribution system across
more than 75 countries. The company competes in three major
category platforms: Health and Wellness, Inner and Outer Beauty and
Nutritional Performance and Weight Management — leading a network
of more than 400,000 exclusive independent Brand Partners,
empowered with the leading social selling tools and technology
around the world.
The company operates the websites NewAge.com,
MaVie.com and Zennoa.com.
Safe Harbor DisclosureThis press release
contains forward-looking statements that are made under the safe
harbor provisions within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. Forward-looking
statements are any statement reflecting management's expectations
regarding future results of operations, economic performance, and
financial condition, including statements related to operating
margins, the acquisitions and integrations of ARIIX and Aliven and
cost synergies and operational efficiencies related thereto, the
acquisition of additional businesses, the impact of the coronavirus
(“COVID-19”) pandemic, and plans for company growth.
Forward-looking statements, specifically those concerning future
performance, are subject to certain risks and uncertainties, and
actual results may differ materially. NewAge competes in a rapidly
growing and transforming industry, and risk factors, including
those disclosed in the company's filings with the Securities and
Exchange Commission, might affect the company's operations. Unless
required by applicable law, the company undertakes no obligation to
update or revise any forward-looking statements.
For investor inquiries about NewAge please
contact:
NewAge Investor Relations:Mindy
EardleyDirector, Public and Investor RelationsTel:
1-801-573-4818Mindy_Eardley@NewAge.com
-
NewAge, Inc. |
UNAUDITED CONDENSED CONSOLIDATED BALANCE
SHEETS |
(In thousands, except per share amounts) |
|
|
|
|
|
|
|
June 30, |
|
|
December 31, |
|
ASSETS |
2021 |
|
|
2020 |
|
|
|
|
|
|
|
Current
assets: |
|
|
|
|
|
Cash and cash equivalents |
$ |
80,922 |
|
|
$ |
43,711 |
|
Trade accounts receivable, net of allowance of $590 and $582,
respectively |
10,470 |
|
|
12,341 |
|
Inventories |
44,219 |
|
|
48,051 |
|
Assets held for sale |
7,088 |
|
|
- |
|
Current portion of restricted cash |
5,568 |
|
|
10,000 |
|
Prepaid expenses and other |
13,086 |
|
|
13,032 |
|
|
|
|
|
|
|
Total current assets |
161,353 |
|
|
127,135 |
|
|
|
|
|
|
|
Long-term
assets: |
|
|
|
|
|
Identifiable intangible assets, net of accumulated
amortization |
164,093 |
|
|
169,611 |
|
Goodwill |
55,281 |
|
|
54,993 |
|
Right-of-use lease assets |
29,741 |
|
|
38,764 |
|
Property and equipment, net of accumulated depreciation |
23,771 |
|
|
28,076 |
|
Restricted cash, net of current portion |
5,969 |
|
|
11,524 |
|
Deferred income taxes |
7,476 |
|
|
7,782 |
|
Deposits and other |
4,771 |
|
|
5,297 |
|
|
|
|
|
|
|
Total assets |
$ |
452,455 |
|
|
$ |
443,182 |
|
|
|
|
|
|
|
LIABILITIES, REDEEMABLE COMMON STOCK, AND STOCKHOLDERS’
EQUITY |
|
|
|
|
|
Current
liabilities: |
|
|
|
|
|
Accounts payable |
$ |
17,111 |
|
|
$ |
22,774 |
|
Accrued liabilities |
65,009 |
|
|
70,007 |
|
Operating lease liability related to right-of-use assets held for
sale |
4,707 |
|
|
- |
|
Current portion of business combination liabilities |
1,140 |
|
|
11,750 |
|
Current maturities of long-term debt |
19,440 |
|
|
18,016 |
|
|
|
|
|
|
|
Total current liabilities |
107,407 |
|
|
122,547 |
|
|
|
|
|
|
|
Long-term
liabilities: |
|
|
|
|
|
Business combination liabilities, net of current portion |
49,013 |
|
|
95,826 |
|
Long-term debt, net of current maturities |
12,063 |
|
|
16,181 |
|
Operating lease liabilities, net of current portion: |
|
|
|
|
|
Lease liability |
26,745 |
|
|
34,788 |
|
Deferred lease financing obligation |
15,543 |
|
|
15,882 |
|
Warrant derivative liability |
5,695 |
|
|
- |
|
Deferred income taxes |
5,091 |
|
|
5,391 |
|
Other |
8,295 |
|
|
8,313 |
|
|
|
|
|
|
|
Total liabilities |
229,852 |
|
|
298,928 |
|
|
|
|
|
|
|
Redeemable Common Stock, 800 shares as of
December 31, 2020 |
- |
|
|
2,101 |
|
|
|
|
|
|
|
Stockholders’
equity: |
|
|
|
|
|
Preferred stock, $0.001 par value per share. Authorized 1,000
shares; no shares issued |
- |
|
|
- |
|
Common Stock, $0.001 par value per share. Authorized 400,000 and
200,000 shares as of June 30, 2021 and December 31, 2020,
respectively; issued and outstanding 136,606 and 99,146 shares
as of June 30, 2021 and December 31, 2020, respectively |
137 |
|
|
99 |
|
Additional paid-in capital |
340,937 |
|
|
236,732 |
|
Obligation to issue 14,551 and 19,704 shares of Common Stock as of
June 30, 2021 and December 31, 2020, respectively |
30,263 |
|
|
54,186 |
|
Note receivable for stock subscription |
- |
|
|
(1,250 |
) |
Accumulated other comprehensive income |
3,478 |
|
|
4,201 |
|
Accumulated deficit |
(152,212 |
) |
|
(151,815 |
) |
Total stockholders' equity |
222,603 |
|
|
142,153 |
|
Total liabilities, redeemable Common Stock, and stockholders'
equity |
$ |
452,455 |
|
|
$ |
443,182 |
|
|
|
|
|
|
|
NewAge, Inc. |
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF
OPERATIONS |
(In thousands, except per share amounts) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Six Months Ended |
|
June 30, |
|
June 30, |
|
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net revenue |
$ |
124,040 |
|
|
$ |
62,637 |
|
|
$ |
249,558 |
|
|
$ |
126,330 |
|
Cost of goods sold |
40,241 |
|
|
24,559 |
|
|
78,358 |
|
|
46,728 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit |
83,799 |
|
|
38,078 |
|
|
171,200 |
|
|
79,602 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
Commissions |
43,320 |
|
|
18,405 |
|
|
90,717 |
|
|
37,920 |
|
Selling, general and administrative |
41,042 |
|
|
26,277 |
|
|
79,901 |
|
|
56,885 |
|
Depreciation and amortization expense |
4,723 |
|
|
1,761 |
|
|
9,398 |
|
|
3,542 |
|
Loss on disposal of Divested Business |
4,339 |
|
|
- |
|
|
4,339 |
|
|
- |
|
Impairment of right-of-use assets |
- |
|
|
400 |
|
|
- |
|
|
400 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses |
93,424 |
|
|
46,843 |
|
|
184,355 |
|
|
98,747 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating loss |
(9,625 |
) |
|
(8,765 |
) |
|
(13,155 |
) |
|
(19,145 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Non-operating income (expense): |
|
|
|
|
|
|
|
|
|
|
|
Interest expense |
(3,040 |
) |
|
(600 |
) |
|
(6,163 |
) |
|
(1,172 |
) |
Gain (loss) from change in fair value of derivatives |
30,829 |
|
|
20 |
|
|
21,216 |
|
|
(306 |
) |
Interest and other income (expense), net |
(53 |
) |
|
342 |
|
|
(405 |
) |
|
725 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes |
18,111 |
|
|
(9,003 |
) |
|
1,493 |
|
|
(19,898 |
) |
Income tax expense |
(740 |
) |
|
(551 |
) |
|
(1,890 |
) |
|
(1,274 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) |
$ |
17,371 |
|
|
$ |
(9,554 |
) |
|
$ |
(397 |
) |
|
$ |
(21,172 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per share of Common Stock: |
|
|
|
|
|
|
|
|
|
|
|
Basic |
$ |
0.11 |
|
|
$ |
(0.10 |
) |
|
$ |
(0.00 |
) |
|
$ |
(0.24 |
) |
Diluted |
$ |
(0.04 |
) |
|
$ |
(0.10 |
) |
|
$ |
(0.08 |
) |
|
$ |
(0.24 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of shares of Common Stock
outstanding: |
|
|
|
|
|
|
|
|
|
|
|
Basic |
143,636 |
|
|
93,003 |
|
|
135,534 |
|
|
89,187 |
|
Diluted |
170,609 |
|
|
93,003 |
|
|
166,323 |
|
|
89,187 |
|
|
|
|
|
|
|
|
|
|
|
|
|
NewAge, Inc. |
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH
FLOWS |
SIX MONTHS ENDED JUNE 30, 2021 AND 2020 |
(In thousands) |
|
|
|
|
|
|
|
2021 |
|
2020 |
|
|
|
|
|
|
CASH FLOWS FROM
OPERATING ACTIVITIES: |
|
|
|
|
|
Net loss |
$ |
(397 |
) |
|
$ |
(21,172 |
) |
Adjustments to reconcile net loss to net cash used in operating
activities: |
|
|
|
|
|
Loss (gain) from change in fair value of derivatives, net |
(21,216 |
) |
|
306 |
|
Depreciation and amortization |
9,596 |
|
|
3,752 |
|
Non-cash lease expense |
6,244 |
|
|
2,792 |
|
Loss on disposal of Divested Business |
- |
|
|
- |
|
Accretion of debt discount |
4,372 |
|
|
302 |
|
Stock-based compensation expense |
4,149 |
|
|
2,449 |
|
Allowance for uncollectible note receivable from Divested
Business |
2,701 |
|
|
- |
|
Impairment of right-of-use assets |
- |
|
|
400 |
|
Expense for make-whole premium and other |
- |
|
|
- |
|
Deferred income tax benefit |
(149 |
) |
|
(173 |
) |
Loss from sale of property and equipment |
60 |
|
|
66 |
|
Other |
118 |
|
|
73 |
|
Changes in operating assets and liabilities, net of effects of
business combination: |
|
|
|
|
|
Accounts receivable |
(37 |
) |
|
(2,276 |
) |
Inventories |
4,681 |
|
|
2,819 |
|
Prepaid expenses, deposits and other |
1,640 |
|
|
517 |
|
Accounts payable |
(5,840 |
) |
|
(551 |
) |
Other accrued liabilities |
(11,482 |
) |
|
(12,900 |
) |
|
|
|
|
|
|
Net cash used in operating activities |
(5,560 |
) |
|
(23,596 |
) |
|
|
|
|
|
|
CASH FLOWS FROM
INVESTING ACTIVITIES: |
|
|
|
|
|
Cash payments for Ariix business combination |
(10,000 |
) |
|
- |
|
Proceeds from sale of equipment |
- |
|
|
159 |
|
Capital expenditures for property and equipment |
(765 |
) |
|
(1,980 |
) |
Net cash used in investing activities |
(10,765 |
) |
|
(1,821 |
) |
|
|
|
|
|
|
CASH FLOWS FROM
FINANCING ACTIVITIES: |
|
|
|
|
|
Proceeds from private placement of Units, net of placement
fee: |
|
|
|
|
|
Fair value of warrants to purchase 7,318 shares of Common
Stock |
14,128 |
|
|
- |
|
Residual fair value of 14,636 shares of Common Stock |
39,673 |
|
|
- |
|
Proceeds from borrowings |
- |
|
|
6,868 |
|
Principal payments on borrowings |
(6,000 |
) |
|
(10,450 |
) |
Debt issuance costs paid |
(21 |
) |
|
(85 |
) |
Proceeds from issuance of common stock |
- |
|
|
25,122 |
|
Payments for deferred offering costs |
(24 |
) |
|
(94 |
) |
Proceeds from exercise of stock options |
528 |
|
|
4 |
|
Principal payments on business combination obligations |
(4,496 |
) |
|
(298 |
) |
Payments under deferred lease financing obligation |
(329 |
) |
|
(319 |
) |
|
|
|
|
|
|
Net cash provided by financing activities |
43,459 |
|
|
20,748 |
|
|
|
|
|
|
|
Effect of foreign currency translation changes |
90 |
|
|
(857 |
) |
|
|
|
|
|
|
Net change in cash, cash equivalents and restricted cash |
27,224 |
|
|
(5,526 |
) |
Cash, cash equivalents and
restricted cash at beginning of period |
65,235 |
|
|
64,571 |
|
|
|
|
|
|
|
Cash, cash equivalents and restricted cash at end of period |
$ |
92,459 |
|
|
$ |
59,045 |
|
|
Three Months Ended |
|
Six Months Ended |
|
June 30, |
|
June 30, |
|
2021 |
|
2020 |
|
2021 |
|
2020 |
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) |
$ |
17,371 |
|
|
$ |
(9,554 |
) |
|
$ |
(397 |
) |
|
$ |
(21,172 |
) |
EBITDA Non-GAAP
adjustments: |
|
|
|
|
|
|
|
|
|
|
|
Interest expense |
3,040 |
|
|
600 |
|
|
6,163 |
|
|
1,172 |
|
Income tax expense |
740 |
|
|
551 |
|
|
1,890 |
|
|
1,274 |
|
Depreciation and amortization expense |
4,822 |
|
|
1,873 |
|
|
9,596 |
|
|
3,752 |
|
|
|
|
|
|
|
|
|
|
|
|
|
EBITDA |
25,973 |
|
|
(6,530 |
) |
|
17,252 |
|
|
(14,974 |
) |
Adjusted EBITDA Non-GAAP
adjustments: |
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation expense |
2,187 |
|
|
1,092 |
|
|
4,149 |
|
|
2,449 |
|
Loss on disposal of Divested Business |
4,339 |
|
|
- |
|
|
4,339 |
|
|
- |
|
Loss (gain) from change in fair value of derivatives |
(30,829 |
) |
|
(20 |
) |
|
(21,216 |
) |
|
306 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA |
$ |
1,670 |
|
|
$ |
(5,458 |
) |
|
$ |
4,524 |
|
|
$ |
(12,219 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP Financial Measures
The primary purpose of using non-GAAP financial
measures is to provide supplemental information that we believe may
be useful to investors and to enable investors to evaluate our
results in the same way we do. We also present the non-GAAP
financial measures because we believe they assist investors in
comparing our performance across reporting periods on a consistent
basis, as well as comparing our results against the results of
other companies, by excluding items that we do not believe are
indicative of our core operating performance. Specifically, we use
these non-GAAP measures as measures of operating performance; to
prepare our annual operating budget; to allocate resources to
enhance the financial performance of our business; to evaluate the
effectiveness of our business strategies; to provide consistency
and comparability with past financial performance; to facilitate a
comparison of our results with those of other companies, many of
which use similar non-GAAP financial measures to supplement their
GAAP results; and in communications with our board of directors
concerning our financial performance. Investors should be aware,
however, that not all companies define these non-GAAP measures
consistently.
_________________________________1EBITDA and
Adjusted EBITDA are non-GAAP financial measures with
reconciliations provided in the table below.
NewAge (NASDAQ:NBEV)
Historical Stock Chart
From Mar 2024 to Apr 2024
NewAge (NASDAQ:NBEV)
Historical Stock Chart
From Apr 2023 to Apr 2024